Cocaine supply has quadrupled in a decade. The synthetic opioid threat may be even harder to stop

Global cocaine production has risen more than fourfold over a decade, methamphetamine trafficking has expanded into new regions and hundreds of newly identified synthetic substances are making illicit drug markets increasingly difficult to monitor. The United Nations Office on Drugs and Crime released its World Drug Report 2026 on June 26, warning that criminal networks are using technology, political instability and changing trade routes to enter new markets faster than governments can adapt.

An estimated 331 million people used an illicit drug during 2024, representing 6.2 percent of the global population aged between 15 and 64. The equivalent proportion was 5.2 percent in 2014, indicating that drug use has increased faster than population growth during the past decade.

Cocaine production reached approximately 4,100 tonnes of pure product in 2024, the highest level recorded and more than four times the estimated output a decade earlier. Methamphetamine seizures also reached unprecedented levels, rising by an average of 13 percent annually as production and trafficking spread beyond established centres in East and South-East Asia.

The report identifies a second, potentially more dangerous transformation in the opioid market. Afghanistan’s opium prohibition has sharply reduced the supply of heroin, but criminal groups are responding by introducing synthetic alternatives such as fentanyls, nitazenes and orphines. Some of these substances are substantially more potent than traditional opioids and can be difficult for users, health services and forensic laboratories to identify quickly.

What does the United Nations World Drug Report 2026 reveal about global drug use?

Cannabis remained the world’s most widely used illicit drug during 2024, with an estimated 256 million users. Opioids were used by approximately 63 million people, amphetamines by 32 million, cocaine by 25 million and ecstasy by 21 million.

The figures do not mean that every user experiences dependence or a drug use disorder. They provide an estimate of people who used a controlled substance at least once during the reporting period and illustrate the scale of demand available to organised criminal networks.

Cannabis use increased by approximately 40 percent between 2014 and 2024. Its estimated prevalence among people aged between 15 and 64 rose from 3.8 percent to 4.8 percent during that period. Changes in public perceptions, decriminalisation and legalisation in parts of North America have altered both consumption patterns and trafficking routes.

The market is also becoming more geographically interconnected. Cannabis was historically produced and distributed mainly within the same regions because cultivation can occur in many climates. However, cannabis originating in North America was identified in seizures across 57 countries and territories outside the region between 2015 and 2024, compared with 11 during the preceding decade.

The broader increase in consumption is occurring alongside the rapid diversification of available substances. Five times more drug types were detected in seizures during 2024 than before 2000, placing growing pressure on national early-warning systems, toxicology laboratories and emergency health services.

Why has global cocaine production risen more than fourfold within only one decade?

Cocaine production exceeded 4,000 tonnes in pure form during 2024, driven by a combination of expanded coca cultivation and rising agricultural and processing productivity. Criminal networks are consequently handling more cocaine than established destination markets may be able to absorb at existing prices.

Western and Central Europe, North America and Oceania remain among the most valuable cocaine markets. Traffickers are nevertheless expanding distribution across Africa and Asia, where several countries recorded some of the world’s fastest growth in cocaine seizures between 2020 and 2024.

The expansion suggests that organised crime groups are no longer relying exclusively on traditional consumer centres. Larger production volumes allow suppliers to test new routes, accept greater interception losses and lower wholesale prices while attempting to establish regular demand in countries where cocaine use was previously limited.

Cocaine purity has generally increased as prices have declined in some markets, making the substance more accessible and potentially increasing the amount consumed. Greater availability can also change how cocaine is used. Consumption is moving beyond nightlife and occasional social settings into more routine patterns among some groups.

Crack cocaine use presents a separate public-health concern. Treatment data indicate an increase in crack-related demand across Western and Central Europe since approximately 2015. Research has also identified rising use among economically disadvantaged communities and among some people moving away from heroin.

Record seizures do not necessarily demonstrate that supply is being contained. When production grows faster than confiscations, authorities can seize larger volumes while the amount reaching consumers continues to rise. The falling price and increasing purity reported in several markets indicate that availability remains high despite major enforcement operations.

How did methamphetamine evolve from a regional market into a worldwide trafficking system?

Methamphetamine production and trafficking were once concentrated more heavily in a limited number of regions. The World Drug Report 2026 shows a more global system emerging, with seizures increasing by an average of 13 percent annually and new destination markets appearing across the Middle East, Africa, Europe and the Pacific.

Myanmar remains the predominant source of methamphetamine in East and South-East Asia. Production is also expanding or attracting suppliers in North America, West Africa, Southern Africa and South-West Asia, reducing the market’s dependence on a single production region.

North American methamphetamine is increasingly crossing the Pacific Ocean towards countries on the Western Pacific Rim. The same movement is contributing to rising trafficking and consumption in Pacific Island states, where limited treatment resources and extensive maritime borders can complicate detection and prevention.

Methamphetamine can be produced close to consumer markets when criminal groups obtain the necessary chemical precursors, laboratory equipment and technical expertise. It does not require the extensive agricultural land used to cultivate coca bushes or opium poppies, allowing production to be moved when enforcement pressure increases.

The drug’s international growth is also connected to changes in other stimulant markets. The collapse of the former Syrian government in December 2024 disrupted established production and distribution networks for captagon. Prices reportedly doubled in some Middle Eastern locations, potentially encouraging users and traffickers to shift towards methamphetamine.

This substitution risk shows why suppressing one drug market does not automatically reduce overall demand. When demand persists, organised criminal groups can offer a different stimulant, modify its appearance or create tablets that resemble an established product.

Why could Afghanistan’s opium ban permanently transform the global opioid market?

Afghanistan was the dominant source of illicit opium before the Taliban introduced a cultivation prohibition in 2022. The measure sharply reduced opium output and restricted the production of heroin derived from Afghan poppies.

Other producing countries have not replaced the lost volume. Myanmar’s opium production increased from approximately 420 tonnes in 2021 to more than 1,000 tonnes in 2025, but this remains far below Afghanistan’s output of more than 6,000 tonnes during 2022. Production in Laos, Mexico and other monitored locations has also been insufficient to close the gap.

The reduced heroin supply could produce a lasting change rather than a temporary shortage. Traffickers are increasingly exploring synthetic opioids that can be manufactured without poppy cultivation and transported in smaller quantities because of their potency.

Fentanyls are already established in parts of North America. Nitazenes and orphines are appearing in a wider range of markets, including Europe and Oceania. These substances may be sold directly, mixed with heroin or incorporated into counterfeit tablets without the consumer knowing what is present.

The number of newly identified synthetic opioids increased by approximately 10 percent in North America during 2024. Europe recorded an increase of more than 80 percent, while Oceania reported growth of approximately 150 percent.

Those percentages refer to the number of different substances detected rather than the total quantity consumed. They nevertheless demonstrate how rapidly manufacturers are modifying chemical formulas to avoid legal controls, complicate testing and replace products removed from the market.

A permanent transition from heroin to synthetic opioids would require major changes in public-health responses. Traditional surveillance based on poppy cultivation and heroin seizures would become less useful, while laboratories would need to identify increasingly unfamiliar compounds with very different potency levels.

What does the discovery of 755 psychoactive substances mean for public safety systems?

The United Nations Office on Drugs and Crime identified 755 new psychoactive substances circulating during 2024. Of these, 118 were reported for the first time, illustrating the speed with which producers are introducing unfamiliar chemical compounds.

New psychoactive substances include synthetic stimulants, cannabinoids, hallucinogens and opioids designed to produce effects similar to controlled drugs while initially avoiding existing legal restrictions. Manufacturers can alter a chemical structure and market the resulting compound before regulators have completed risk assessments or formally prohibited it.

This cycle creates difficulties for police, customs agencies and prosecutors because officers may encounter a substance that is not covered clearly by national schedules. Governments can use broader chemical-family controls, but those systems must balance rapid action with accurate scientific classification.

Medical personnel face a different challenge. Emergency teams may not know which substance a patient has consumed, particularly when powders, tablets or liquids contain several compounds. Standard toxicology tests may fail to detect a newly introduced drug, delaying appropriate treatment and obscuring the cause of serious illness or death.

Consumers also face increasing uncertainty. A tablet sold as an established substance may contain a far more potent opioid, stimulant or synthetic cannabinoid. The physical appearance of the product cannot reliably identify its chemical composition or dosage.

Early-warning networks are therefore becoming central to drug policy. Information must move quickly between hospitals, toxicology laboratories, law-enforcement agencies, treatment services and neighbouring countries when a dangerous compound is detected.

Why do record drug seizures fail to prove that international enforcement is winning?

Drug seizures measure what authorities intercept rather than the total amount produced or consumed. Record confiscations may reflect stronger enforcement, but they can also indicate that traffickers are moving historically large quantities.

The cocaine market illustrates this contradiction. Production, seizures and use can all rise simultaneously when total output expands faster than law-enforcement capacity. Criminal networks can treat confiscated shipments as an operating cost when profits from successful deliveries remain sufficiently high.

Containerised maritime trade allows illicit cargo to be hidden among enormous volumes of legitimate goods. Inspecting every container would be commercially and operationally impossible, forcing customs authorities to depend on intelligence, risk profiling, scanning technology and international cooperation.

Traffickers are also using digital communications, encrypted platforms, online payments and new logistical methods to coordinate production and delivery. Political conflict and weak governance create additional opportunities where armed groups, corrupt officials or poorly resourced institutions provide protection or limited oversight.

Enforcement remains essential because major seizures can remove harmful substances, disrupt networks and generate intelligence about financial and logistical structures. The report nevertheless indicates that confiscation alone cannot reduce demand, prevent substitution or address the social conditions that increase vulnerability to harmful drug use.

The United Nations Office on Drugs and Crime has called for stronger intelligence sharing, coordinated operations and more effective action against organised criminal groups. The institution has also emphasised prevention, treatment and social services rather than treating drug use solely as a policing issue.

How could the changing drug market affect health systems, communities and governments?

The immediate health risk comes from unpredictability. Higher cocaine purity, expanding methamphetamine supply and increasingly potent synthetic opioids can expose users to substances or dosages they did not intend to consume.

Health systems must respond to several different emergencies at once. Opioid overdoses may require rapid access to naloxone, while stimulant intoxication can involve severe agitation, overheating, cardiovascular distress or psychosis. Mixed-drug consumption can make symptoms and treatment more complicated.

Treatment systems may also be designed around older consumption patterns. A service created mainly for heroin dependence may not have sufficient capacity or specialised programmes for crack cocaine, methamphetamine or new synthetic substances.

Drug markets have broader institutional effects. Trafficking revenue can finance armed organisations, distort local economies and increase corruption in ports, border agencies, police services and political systems. Competition between networks can drive violence even in countries where domestic consumption is relatively low.

The report also cautions against treating drug use as an isolated cause of crime or social instability. Outcomes are influenced by homelessness, poverty, poor mental health, personal history, family conditions and the availability of treatment and social support.

Governments therefore face a combined challenge involving public health, organised crime, financial investigation, border security and social policy. The World Drug Report 2026 indicates that criminal markets are adapting across all of those areas simultaneously.

What are the key takeaways from the United Nations World Drug Report 2026?

• Global illicit drug use reached an estimated 331 million people during 2024, representing 6.2 percent of the population aged between 15 and 64, compared with 5.2 percent ten years earlier.
• Cocaine production rose to approximately 4,100 tonnes of pure product in 2024, more than four times the estimated level recorded a decade earlier as cultivation and processing productivity increased.
• Methamphetamine seizures grew by an average of 13 percent annually as production and trafficking expanded from established Asian centres into North America, Africa, Europe, the Middle East and Pacific Island markets.
• Afghanistan’s opium ban severely reduced global heroin supply, while increased production in Myanmar, Laos and Mexico remained insufficient to replace the more than 6,000 tonnes Afghanistan produced during 2022.
• Traffickers are introducing synthetic opioids such as fentanyls, nitazenes and orphines as alternatives to heroin, creating greater overdose risks because small quantities can be exceptionally potent and difficult to identify.
• Authorities identified 755 new psychoactive substances circulating in 2024, including 118 reported for the first time, placing greater pressure on toxicology laboratories, early-warning networks and emergency medical services.
• Cannabis remained the most widely used illicit drug with approximately 256 million users, while opioids reached 63 million users, amphetamines 32 million, cocaine 25 million and ecstasy 21 million.
• Record seizures do not necessarily show that supply is falling because criminal organisations are producing and transporting larger volumes, allowing confiscations, availability and consumption to increase at the same time.